SCHEMBL8419129

SCHEMBL8419129

COc1ccc2c(n1)C(C)(SC)c1ncccc1C(=O)N2C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 4/20 0.35
PDE10A Q9Y233 3/20 0.35
PDE2A O00408 2/20 0.35
IDO1 P14902 1/20 0.34
BRD4 O60885 5/20 0.33
ALDH1A1 P00352 2/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
POLB P06746 1/20 0.32
PKM P14618 1/20 0.32
CASP1 P29466 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
SCN9A Q15858 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ALOX5 P09917 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8339203 0.72 KDM4E (0.37) IDH1PDE10APDE2ABRD4ALDH1A1
SCHEMBL8300415 0.70 CYP3A4 (0.45) IDH1BRD4
SCHEMBL8304233 0.69 ALDH1A1 (0.47) IDH1BRD4ALDH1A1LMNAPOLB
SCHEMBL8418964 0.68 KDM4E (0.40) PDE10APDE2ABRD4ALDH1A1LMNA
SCHEMBL8421674 0.67 ALDH1A1 (0.38) BRD4ALDH1A1KDM4EHPGD
SCHEMBL6073371 0.67 POLB (0.37) IDH1POLBTDP1SCN9AMAPT
SCHEMBL22188020 0.62 MEN1 (0.38) ALDH1A1PKMSMN1; SMN2TDP1MAPT
SCHEMBL29520155 0.62 MEN1 (0.38) ALDH1A1PKMSMN1; SMN2TDP1MAPT
SCHEMBL8790761 0.61 TTR (0.50) BRD4ALDH1A1HSD17B10
SCHEMBL8417200 0.61 KDM4E (0.33) IDH1ALDH1A1KDM4EMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5908841-A 5,11-dihydro-6H-dipyrido 3,2-b:2',3'-e!azepine-6-ones and their use in the prevention of treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1999-06-01 US disclosed